Tollip attenuated the hypertrophic response of cardiomyocytes induced by IL-1beta

Frontiers in Bioscience

Volumn 14, Issue 7, 2009, Pages 2747-2756

  Hu, Yulong ^a,b   Li, Ting ^a   Wang, Yongmei ^a   Li, Jing ^a   Guo, Lin ^a   Wu, Meiling ^a   Shan, Xiaohong ^a   Que, Lingli ^a   Ha, Tuanzhu ^c   Chen, Qi ^a   Kelley, Jim ^c   Li, Yuehua ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b XIANGNAN UNIVERSITY   (China)

^c East Tennessee State University   (United States)

Author keywords

Cardiac hypertrophy; IRAK 1; MAPK; NF kappaB; Signaling pathway; Tollip

Indexed keywords

MUS;

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; MYD88 PROTEIN, MOUSE; MYELOID DIFFERENTIATION FACTOR 88; PRIMER DNA; SIGNAL PEPTIDE; TOLLIP PROTEIN, MOUSE;

ANIMAL; ARTICLE; C57BL MOUSE; CARDIOMEGALY; CELL CULTURE; CHEMICALLY INDUCED DISORDER; ECHOCARDIOGRAPHY; ENZYMOLOGY; GENETICS; HEART MUSCLE; IMMUNOPRECIPITATION; MALE; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CARDIOMEGALY; CELLS, CULTURED; DNA PRIMERS; ECHOCARDIOGRAPHY; IMMUNOPRECIPITATION; INTERLEUKIN-1BETA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; MYOCARDIUM; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 63849247212     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3411     Document Type: Article

References (30)

1. Patricia Cristofaro, Steven M Opal: Role of Toll-like receptors in infection and immunity: clinical implications. Drugs 66, 15-29 (2006). (Pubitemid 43144961)
2. Fang Hua, Tuanzhu Ha, Jing Ma, Xiang Gao, Jim Kelley, David L Williams, I William Browder, Race L Kao and Chuanfu Li: Blocking the MyD88-dependent pathway protects the myocardium from ischemia/reperfusion injury in rat hearts. Biochem Biophys Res Commun 338, 1118- 1125 (2005). (Pubitemid 41597753)
3. Tuanzhu Ha, Fang Hua, Yuehua Li, Jing Ma, Xiang Gao, Jim Kelley, Aiqui Zhao, Georges E Haddadin, Daivd L Williams, I William Browder, Race L Kao, and Chuanfu Li: Blockade of MyD88 attenuates cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure overload-induced cardiac hypertrophy in vivo. Am J Physiol Heart Circ Physiol 290, H985-994 (2006).
4. Kimberly Burns, Sophie Janssens, Brian Brissoni, Natalia Olivos, Rudi Beyaert and Jurg Tschopp: Inhibition of interleukin 1 receptor/Toll- like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J Exp Med 197, 263-268 (2003). (Pubitemid 36152320)
5. Kimberly Burns, Jonathan Clatworthy, Laurence Martin, Fabio Martinon, Chris Plumpton, Barbara Maschera, Alan Lewis, Keith Ray, Jurg Tschopp and Filippo Volpe: Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nature Cell Biology 2, 346-351 (2000).
6. Guolong Zhang and Sankar Ghosh: Negative regulation of Toll-like receptor mediated signaling by Tollip. J Biol Chem 277, 7059-7065 (2002). (Pubitemid 34953094)
7. Yonca Bulut, Emmanuelle Faure, Lisa Thomas, Ozlem Equils, and Moshe Arditi Cooperation of Tolllike receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Tolllike Tolllike receptor 2 signaling. J Immunol 167, 987-994 (2001). (Pubitemid 32660856)
8. Tao Li, Jean Hu, Liwu Li. Characterization of Tollip protein upon Lipopolysaccharide challenge. Molecular Immunology 41, 85-92 (2004). (Pubitemid 38609400)
9. Tuanzhu Ha, Yuehua Li, Fang Hua, Jing Ma, Xiang Gao, Jim Kelley, Aiqiu Zhao, Georges Haddad, David L Williams, I William Browder, Race L Kao, and Chuanfu Li: Reduced cardiac hypertrophy in Toll-like receptor 4- deficient mice following pressure overload. Cardiovasc Res 68, 224-234 (2005). (Pubitemid 41428419)
10. Yuehua Li, Tuanzhu Ha, Xiang Gao, Jim Kelley, David L Williams, I William Browder, Race L Kao, and Chuanfu Li: NF-kappaB activation is required for the development of cardiac hypertrophy in vivo. Am J Physiol Heart Circ Physiol 287, H1712-1720 (2004). (Pubitemid 39313278)
11. Y Liao, F Ishikura, S Beppu, M Asakura, S Takashima, H Asanuma, S Sanada, J Kim, H. Ogita, T Kuzuya, K Node, M Kitakaze, and M Hori: Echocardiographic assessment of LV hypertrophy and function in aorticbanded mice: necropsy validation. Am J Physiol Heart Circ Physiol 282, H1703-1708 (2002). (Pubitemid 34654838)
12. Masao Takemoto, Koichi Node, Hironori Nakagami, Yulin Liao, Michael Grimm, Yaeko Takemoto, Masafumi Kitakaze, and James K Liao: Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 108, 1429-37 (2001). (Pubitemid 33091980)
13. J M Edelberg, W C Aird and R D Rosenberg: Enhancement of murine cardiac chronotropy by the molecular transfer of the human beta2 adrenergic receptor cDNA. J Clin Invest 101, 337-343 (1998). (Pubitemid 28067330)
14. Mitsuhiro Azuma, Kyoko Takahashi, Tsuyoshi Fukuda, Yuko Ohyabu, Isamu Yamamoto, Syokei Kim, Hiroshi Iwao, Stephen W Schaffer and Junichi Azuma: Taurine attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac myocytes. Eur J Pharmacol 403, 181-188 (2000).
15. Hua Chen, Xueyin N Huang, Alexandre F R Stewart, and Jorge L Sepulveda: Gene expression changes associated with fibronectin-induced cardiac myocyte hypertrophy. Physiol Genomics 18, 273-283 (2004). (Pubitemid 39319510)
16. Fang Hua, Tuanzhu Ha, Jing Ma, Yuehua Li, Jim Kelley, Xiang Gao, I William Browder, Race L Kao, David L Williams, and Chuanfu Li: Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice Is mediated through a phosphoinositide 3-kinase-dependent mechanism. J Immunol 178, 7317-7324 (2007). (Pubitemid 46847459)
17. Chuanfu Li, Tuanzhu Ha, Jim Kelley, Xiang Gao, Yufeng Qiu, Race L Kao, William Browder, and David L Williams: Modulating Toll-like receptor mediated signaling by (1-3)-beta-D-glucan rapidly induces cardioprotection. Cardiovasc Res 61, 538-547 (2004). (Pubitemid 38210159)
18. Diana Boraschi and Aldo Tagliabue: The interleukin-1 receptor family. Vitamins & Hormones 74, 229-254 (2006).
19. Jeffery D Molkentin and Gerald W Dorn: Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physio 63, 391-426 (2001). (Pubitemid 32304323)
20. T Shioi, A Matsumori, Y Kihara, M Inoko, K Ono, Y Iwanaga, T Yamada, A Iwasaki, K Matsushima, and S Sasayama: Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload. Circ Res 81, 664-671 (1997). (Pubitemid 27467200)
21. Kayoko Ogimoto, Marvin K Harris Jr, and Brent E Wisse: MyD88 is a key mediator of anorexia, but not weight loss, induced by lipopolysaccharide and interleukin- 1 beta. Endocrinology 147, 4445-4453 (2006). (Pubitemid 44268396)
22. Zhaodan Cao, William J Henzel, and Xiong Gao: IRAK: a kinase associated with the interleukin-1 receptor. Science 271, 1128-1131 (1996). (Pubitemid 26075229)
23. Emma-Louise Cooke, Iain J Uings, Chulin L Xia, Patricia Woo, and Keith P Ray: Functional analysis of the interleukin-1- receptor-associated kinase (IRAK-1) in interleukin-1 beta-stimulated nuclear factor kappa B (NFkappa B) pathway activation: IRAK-1 associates with the NF-kappa B essential modulator (NEMO) upon receptor stimulation. Biochem J 359, 403-410 (2001). (Pubitemid 32999786)
24. Alexander Roeder, Carsten J Kirschning, Rudolf A Rupec, Martin Schaller, Gunther Weindl, and Hans Christian Korting: Toll-like receptors as key mediators in innate antifungal immunity. Med Mycol 42, 485-498 (2004). (Pubitemid 40109561)
25. Arnaud Didierlaurent, Brian Brissoni, Dominique Velin, Natalia Aebi, Aubry Tardivel, Edgar Kaslin, Jean Claude Sirard, Georgi Angelov, Jurg Tschopp, and Kimberly Burns: Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide. Mol Cell Biol 26, 735-742 (2006). (Pubitemid 43146471)
26. S. Kobayashi, M Yano, M Kohno, M Obayashi, Y Hisamatsu, T Royke, T Ohkusa, K Yamakawa, and M Matsuzaki: Influence of aortic impedance on the development of pressure-overload left ventricular hypertrophy in rats. Circulation 94, 3362-3368 (1996). (Pubitemid 26427510)
27. Antonino Nicoletti and Jean-Baptiste Michel: Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors. Cardiovasc Res 41, 532-543 (1999). (Pubitemid 29130617)
28. Christine A Petersen, Katherine A Krumholz, and Barbara A Burleigh: Toll-like receptor 2 regulates interleukin-1 beta-dependent cardiomyocyte hypertrophy triggered by Trypanosoma cruzi. Infection & Immunity 73, 6974-6980 (2005). (Pubitemid 41368866)
29. Gianluigi Condorelli, Carmine Morisco, Michael V G Latronico, Pier Paolo Claudio, Paul Dent, Philip Tsichlis, Gerolama Condrelli, Giacomo Frati, Alessandra Drusco, Carlo M Croce and Claudio Napoli: TNF-alpha signal transduction in rat neonatal cardiac myocytes: definition of pathways generating from the TNF-alpha receptor. FASEB J 16, 1732-177 (2002).
30. J N Palmer, W E Hartogensis, M Patten, F D Fortuin and C S Long: Interleukin-1beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture. J Clin Invest 95, 2555-2564 (1995).